KL-001
Asset
Postbiotic based on Lactiplantibacillus plantarum KM2 intended to improve muscle strength.
- Stage
- Clinical, no phase
- Modality
- Microbiome
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Sarcopenia
Clinical, no phase, hitnews.co.kr, Oct 15, 2026
In the full profile
- Owner and partners2
- Competitors2
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.